H3G34-突变性质瘤-分子病变发生和治疗选择的审查
Anthony V Nguyen1, Jose M Soto1, Sarah-Marie Gonzalez1
1Department of Neurosurgery, Baylor Scott and White Medical Center, Temple, TX 76508, USA.
Biomedicines
|July 29, 2023
概括
患有H3.3-G34R/V突变的儿科类型的扩散半球质瘤是研究不足的. 这篇综述考察了它们的质形成,诊断,治疗和未来的治疗策略,强调了预后不佳.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 2021年世卫组织中枢神经系统瘤分类引入了H3.3-G34R/V突变质瘤 (儿科类型的扩散半球质瘤),以及H3-K27M改变的质瘤 (扩散中线质瘤).
- 无论是H3.3-G34R/V还是H3-K27M质瘤都与预后不佳有关,特别是在儿科患者群体中.
- 与H3-K27M变异性质瘤相比,H3.3-G34R/V变异性质瘤仍然被研究不足.
研究的目的:
- 巩固目前关于H3.3-G34R/V突变质瘤的知识.
- 阐明驱动这种特定亚型中的质生成的分子机制.
- 审查诊断标准,治疗选择,长期结果和潜在的未来疗法.
主要方法:
- 对H3.3-G34R/V突变质瘤的研究进行了全面的文献综述.
- 对分子机制的分析,包括胆在质生成中的作用.
- 综合了关于临床诊断,治疗干预和患者结果的数据.
主要成果:
- H3.3-G34R/V突变是儿科类型扩散半球质瘤的关键驱动因素.
- 了解质生成对于开发向疗法至关重要.
- 目前的治疗策略提供了有限的长期生存益处.
结论:
- H3.3-G34R/V突变质瘤需要进一步的研究注意力,因为他们的预后不佳和研究不足的性质.
- 了解分子机制的进步可能会导致新的治疗点.
- 未来的研究应该专注于改善这些罕见的儿科脑瘤的诊断和治疗疗效.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.0K
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.9K
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...